Showing results (21-30 of 81) with videos related to

Sort By:
Pageof 9
Breast Cancer Research : BCR|November 11, 2005
Targeted therapy against Bcl-2-related proteins in breast cancer cellsManabu Emi, Ryungsa Kim, Kazuaki Tanabe, et al.
Oncology Reports|October 10, 2003
Death receptor-dependent and -independent pathways in anticancer drug-induced apoptosis of breast cancer cellsRyungsa Kim, Kazuaki Tanabe, Manabu Emi, et al.
Oncology Reports|October 8, 2005
CD4+CD25+ regulatory T cells in the peripheral blood of patients with breast cancer and non-small cell lung cancerRiki Okita, Toshiaki Saeki, Shigemitsu Takashima, et al.
Oncology Reports|April 17, 2002
Analysis of T cell receptors reactive with squamous cell carcinoma antigen SART-1 presented by the HLA-A24 moleculeKatsuhiko Shimizu, Yoshiyuki Yamaguchi, Koji Ohta, et al.
Anticancer Research|January 18, 2003
Novel system for generating cytotoxic effector lymphocytes using carcinoembryonic antigen (CEA) peptide and cultured dendritic cellsKoji Ohta, Yoshiyuki Yamaguchi, Katsuhiko Shimizu, et al.
Breast Cancer Research : BCR|February 19, 2019
Correction to: Targeted therapy against Bcl-2-related proteins in breast cancer cellsManabu Emi, Ryungsa Kim, Kazuaki Tanabe, et al.
Cancer|April 15, 2005
Modulation of tamoxifen sensitivity by antisense Bcl-2 and trastuzumab in breast carcinoma cellsRyungsa Kim, Kazuaki Tanabe, Manabu Emi, et al.
Anti-Cancer Drugs|October 11, 2003
Chemosensitivity testing for gastrointestinal cancer: survival benefit potential and limitationsRyungsa Kim, Manabu Emi, Kazuaki Tanabe, et al.
International Journal of Oncology|December 5, 2003
Potential roles of antisense therapy in the molecular targeting of genes involved in cancer (review)Ryungsa Kim, Kazuaki Tanabe, Manabu Emi, et al.
Pageof 9